CLASSIFICATION
Glycoprotein hormones, alpha polypeptide
DOSAGE
500-3000 IU, administered 1-3 times per week
ACNE
Possible
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Merck
WAREHOUSE
International Warehouse 2
SUBSTANCE
Human Chorionic Gonadotropin
Experience the power of Ovitrelle 250 mcg (6500 IU), a cutting-edge injectable medication expertly produced by Merck. Each pre-filled pen delivers 250 mcg of choriogonadotropin alfa in a convenient 0.5 ml solution, equating to approximately 6,500 IU.
Choriogonadotropin alfa is a synthetic replica of the natural hormone human chorionic gonadotropin (hCG), often referred to as the 'pregnancy hormone.' This critical hormone is initially produced by the developing placenta post-conception and later by the syncytiotrophoblast, a vital component of the placenta. hCG's multifaceted roles include appetite suppression and mobilization of fat for energy. It is widely utilized to induce ovulation and combat female infertility, while also enhancing sperm production in men. Bodybuilders frequently integrate it into steroid cycles and post-cycle therapy (PCT) to minimize weight gain and promote testosterone levels.
Ovitrelle is a favorite among bodybuilders and athletes at the conclusion of anabolic-androgenic steroid cycles, as it helps prevent muscle tissue breakdown and restore normal testicular function, which can be compromised after extended steroid use. This powerful medication aids in normalizing testicular size and is particularly effective when paired with a low-calorie diet, enabling athletes to shed fat while preserving muscle mass. Women may also leverage Ovitrelle in conjunction with a calorie-restricted diet for effective fat loss.
The standard dosing regimen for Ovitrelle during cycles ranges from 500 IU to 3000 IU weekly (1-3 times a week). Frequent injections ensure stable blood levels, while a single high dose may elevate estrogen levels due to testosterone aromatization, leading to potential gynecomastia. Some users have reported taking 6000 IU for six consecutive days, but this practice poses risks and may vary by individual. For post-cycle therapy, lower doses of approximately 250 to 500 IU daily for 2 to 3 weeks are recommended to facilitate recovery from testicular atrophy. Bodybuilders should conduct an hCG cycle for 2 to 3 weeks and allow a minimum month-long rest between cycles. Ovitrelle can be effectively combined with Clomid or Nolvadex during PCT, with these medications continuing even after hCG administration ceases. It is advisable to initiate the hCG regimen towards the end of a steroid cycle, ideally in the final week.
While Ovitrelle is generally well-tolerated, potential severe side effects may include intense pelvic pain, swelling in the extremities, abdominal discomfort, difficulty breathing, sudden weight gain, diarrhea, nausea, or vomiting. Common side effects may include headaches, restlessness, mild swelling or water retention, depression, and breast tenderness or swelling; injection site reactions such as pain, swelling, or irritation can also occur. In younger males, the medication may trigger early puberty signs, including voice deepening, pubic hair growth, and increased acne or perspiration.